Drugs / BC-819/PEI
last change Oct 2017 re-read 2 minutes ago

BC-819/PEI

Developed for
bladder transitional cell carcinoma
Investigated by
Anchiano Therapeutics Israel Ltd.

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01878188 Feb 2013 → Oct 2015 bladder transitional cell carcinoma Anchiano Therapeutics Israel Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BC-819/PEI ClinicalTrials.gov intervention name — accepted as the source's own label NCT01878188
Route Other “Intravesical instillation” NCT01878188